Skip to main content
. 2017 Sep 11;8(46):81511–81519. doi: 10.18632/oncotarget.20828

Table 5. Hemorrhage condition between the experimental group and verification group with the comparison between actual and predicted incidence of hemorrhage.

Risk gradation Score CNEG (n, %) IEG (n, %) CNVG (n, %) IVG (n, %) P value
Low-risk 1277 (95.2%) 25 (2.0%) 434 (97.1%) 9 (2.1%) 0.881
0 486 (34.9%) 3 (0.6%) 142 (31.8%) 1 (0.7%)
1 568 (42.3%) 11 (1.9%) 201 (45.0%) 3 (1.5%)
2 223 (16.6%) 11 (4.9%) 91 (20.4%) 5 (5.5%)
High-risk 65(4.8%) 9(13.8%) 13(2.9%) 3(23.1%) 0.400
3 55 (4.1%) 6 (10.9%) 11 (2.5%) 2 (18.2%)
4 7 (0.5%) 1 (14.3%) 2 (0.4%) 1 (50.0%)
5 3 (0.2%) 2 (66.7%) 0 /

CNEG: Case number of experimental group; IEG: Incidence in experimental group.

CNVG: Case number of verification group; IVG: Incidence in verification group.